Controversies relating to pre-participation cardiovascular screening in young athletes: Time for a realistic solution?
- Correspondence to: Sanjay Sharma, Dept. of Cardiology, Kings College Hospital, Kings College Hospital, Denmark Hill, London, SE5 9RS, United Kingdom; ssharma21{at}hotmail.com
- Received 16 September 2009
- Accepted 18 September 2009
- Published Online First 21 October 2009
Abstract
The sudden death of any young individual is a tragic event that causes immeasurable damage to family lives. The sudden death of a young athlete from a cardiac disorder is particularly emotive and is often associated with considerable media coverage, drawing attention to the youth and athletic prowess of the individual and the number of life years lost consequent to a cardiac disorder that could have been detected during life. Most exercise related sudden cardiac deaths are attributed to congenital or hereditary cardiac disorders that are asymptomatic in the vast majority of victims.1,2 Unsurprisingly the death of a young athlete often galvanises urgent discussions relating to pre-participation cardiac screening (PPS) involving members of the community, sports physicians and sporting governing bodies.







